Raffa Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Raffa Wealth Management's TAK Position: Q3 2026 in Review
Raffa Wealth Management increased its Takeda Pharmaceutical (TAK) stake by 29% in Q3 2026, buying an estimated $1.08K and bringing the position to 269 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #591.
Raffa Wealth Management first reported a position in TAK in Q1 2020 and has held it in 27 quarters since. The position peaked at $7.08K in Q4 2020. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Raffa Wealth Management held 269 shares of Takeda Pharmaceutical worth $4.89K as of Q3 2026.
- Raffa Wealth Management bought 61 Takeda Pharmaceutical shares in Q3 2026, an estimated $1.08K.
- Takeda Pharmaceutical made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #591 holding.
- Raffa Wealth Management first reported a position in Takeda Pharmaceutical in Q1 2020 and has held it in 27 quarters since.
- Raffa Wealth Management's Takeda Pharmaceutical position peaked at $7.08K in Q4 2020.
- 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.